Form 8-K - Current report:
SEC Accession No. 0001193125-19-143648
Filing Date
2019-05-10
Accepted
2019-05-10 07:56:02
Documents
3
Period of Report
2019-05-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d744597d8k.htm 8-K 19176
2 EX-99.1 d744597dex991.htm EX-99.1 45094
3 GRAPHIC g744597g0509045306262.jpg GRAPHIC 4611
  Complete submission text file 0001193125-19-143648.txt   72055
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 19812883
SIC: 2834 Pharmaceutical Preparations